Biotech growth story....hideously oversold, page-3

Pleasure Mike.

I don't think the sellers realise that a decent amount of the expenditure was on the patents which are critical to building the company. Epichem is full of Phd's and smart operators and with any business about to accelerate the growth profile you are going to have costs. As I have always said, selling begets more selling and it only takes a small number to throw their stock out and it drags down sentiment for others. Dr's Hopkins, Mollard, Aston and Best are first class operators, the potential market for MPL is ginormous and then you have Epichem in the background building it's own "blue sky".

I have been prominent on Hiotcopper since 1997 and was the major writer here for a few years. I have seen stocks halve and then some that were perfectly sound all because of the slightest amount of negativity and the on-going paranoia that my posts might have some evil motive.

[email protected]